Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition
NCT01565278 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2016-05-12
Summary
Patients who are not able to eat normally for a longer time require parenteral nutrition, i.e. they receive liquids and nutrients directly into their veins. This can have many long-term side effects, including liver problems. This study will examine whether a specific lipid emulsion containing fish oil can improve liver disease in patients on parenteral nutrition. The investigators will compare changes in bilirubin and liver enzymes after 3 months in 10 patients receiving standard lipid emulsion to 10 patients receiving standard lipids + a fish-oil containing emulsion. The investigators will also assess liver histology, the kind of fat, oxidative stress and gene expression in the liver at the beginning and after 6 months of fish-oil. The investigators also want to compare the baseline values from all 20 patients to 20 healthy controls. This will help to explain how fish oil may improve liver disease in patients on parenteral nutrition.
Conditions
- Total Parenteral Nutrition-induced Cholestasis
Interventions
- DRUG
-
Soybean oil (Standard treatment)
1\. Standard treatment: Soybean oil based emulsion: 0.25 g/kg/TPN day
- DRUG
-
Soybean oil + Fish oil
Intralipid+Omegaven: 0.25 g/kg/TPN Intralipid day+0.4 g/kg/TPN Omegaven day for 6 months
Sponsors & Collaborators
-
ASPEN Rhoads Research Foundation
collaborator INDUSTRY -
Fresenius Kabi
collaborator INDUSTRY -
University of Alberta
collaborator OTHER -
Foothills Medical Centre
collaborator OTHER -
St. Boniface Hospital
collaborator OTHER -
Hamilton Health Sciences Corporation
collaborator OTHER -
St. Paul's Hospital, Canada
collaborator OTHER -
Johane Allard
lead OTHER
Principal Investigators
-
Johane P Allard, MD,FRCPC · University Health Network, Toronto
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- Canada
Study Locations
More Related Trials
-
The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease
NCT00819338 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition
NCT02468713 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of a Spread With Added Plant Sterols and Omega-3 Fatty Acids on Blood Lipids
NCT02728583 ·Status: COMPLETED ·Phase: NA
-
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
NCT01277237 ·Status: COMPLETED ·Phase: PHASE3
-
Omegaven Expanded Access Protocol
NCT02121769 ·Status: NO_LONGER_AVAILABLE
-
The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II
NCT01979874 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Plant Sterols Esterified to Fish Oil Fatty Acids on Plasma Lipid Levels
NCT00441480 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study on the Lipid-lowering Effect of Plant Sterols and Fish Oil
NCT01313988 ·Status: COMPLETED ·Phase: NA
-
Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients
NCT02201160 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function
NCT00600912 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation
NCT01310270 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 PUFA Supplementation in NAFLD Patients
NCT00230113 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
NCT03869957 ·Status: COMPLETED ·Phase: NA
-
Effects Of Fish Oil Emulsion On Severe Acute Pancreatitis Patients
NCT01745861 ·Status: COMPLETED ·Phase: PHASE2
-
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
NCT01577056 ·Status: UNKNOWN ·Phase: NA
-
EPA Supplementation in Cancer Patients Receiving Abdominal Radiotherapy -
NCT04687124 ·Status: UNKNOWN ·Phase: PHASE4
-
Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride
NCT01488747 ·Status: COMPLETED ·Phase: NA
-
Explore Effects of Dietary Fish Oil in Human Skin
NCT03122912 ·Status: TERMINATED ·Phase: PHASE1
-
A Parallel Bioavailability Study of Fish Oil-Ethyl Ester Versus Fish Oil-Triglyceride Versus Krill Oil
NCT02427373 ·Status: COMPLETED ·Phase: NA
-
A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA
NCT06629103 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
NCT01690312 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Omega-3 Monoglycerides
NCT04382027 ·Status: COMPLETED ·Phase: NA
-
Different Lipid Emulsions in Acute Lung Injury Patients
NCT01814956 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Fish Oil to Reduce ALT Levels in Adolescents
NCT00694746 ·Status: TERMINATED ·Phase: PHASE1